Restylane
Restylane is the original aesthetic hyaluronic acid dermal filler brand operated by Galderma Laboratories, offering nine FDA-approved HA fillers for facial and hand rejuvenation, distributed exclusively through licensed healthcare professionals across the United States.
- Company typePrivate
- Founded1996
- HeadquartersDallas, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Restylane firmographics
Firmographics- Name
- Restylane
- Legal name
- Galderma Laboratories, L.P.
- Website
- https://restylaneusa.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Restylane is the original aesthetic hyaluronic acid dermal filler brand operated by Galderma Laboratories, offering nine FDA-approved HA fillers for facial and hand rejuvenation, distributed exclusively through licensed healthcare professionals across the United States.
- Ownership category
- akta.pro rank
Restylane industry classification
Industry- Product category
- Aesthetic Dermal Fillers
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Professional Skincare & Facial Treatments (CRABALAF)
- akta.pro secondary industry
- Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK)
Keywords
Where Restylane is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Restylane business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Marketing or Sales, Operations, Personnel
Revenue model
- Dermal Filler Product Sales: Revenue generated from sale of HA dermal filler products to licensed healthcare professionals. Products are prescription medical devices administered by certified aesthetic injectors. Restylane products can only be administered by licensed healthcare professionals and cannot be purchased online by consumers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Product pricing varies by provider and treatment area |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Restylane product offering
Product offeringCore offering
Restylane is a portfolio of nine FDA-approved hyaluronic acid (HA) dermal fillers sold by Galderma Laboratories, L.P. exclusively to licensed healthcare professionals for non-surgical aesthetic treatments including lip augmentation, cheek and chin enhancement, undereye hollow correction, nasolabial fold and marionette line softening, and hand rejuvenation. Products are administered by certified aesthetic injectors and built on two proprietary gel technologies — NASHA® (precision/structure) and XpresHAn™ (flexibility/movement) — to address distinct facial areas and dynamic expressions. Supporting infrastructure includes the ASPIRE Galderma Rewards loyalty program, the GAIN injector network, and the Find a Specialist locator.
Product overview
Restylane is a comprehensive portfolio of hyaluronic acid (HA) dermal fillers consisting of 9 distinct FDA-approved products: Restylane, Restylane-L, Restylane Lyft, Restylane Silk, Restylane Kysse, Restylane Refyne, Restylane Defyne, Restylane Contour, and Restylane Eyelight. The portfolio is built on two proprietary gel technologies: NASHA Technology (used in Restylane-L, Restylane Lyft, Restylane Silk, Restylane Eyelight) engineered for precision and structure with firm gel texture for pronounced lift; and XpresHAn Technology (used in Restylane Contour, Restylane Kysse, Restylane Defyne, Restylane Refyne) designed for flexibility and natural movement in dynamic facial areas. The products target various treatment areas including lips, cheeks, chin, marionette lines, nasolabial folds, undereye hollows, and hands. Supporting infrastructure includes the ASPIRE Galderma Rewards loyalty program, GAIN professional network for healthcare providers, and a Find a Specialist service.
Differentiator
Problem solved
Functional benefit
Brands
- ASPIRE Galderma Rewards: A loyalty rewards program for patients receiving Galderma aesthetic treatments, including Restylane products. Members earn points for treatments and can redeem for savings.
- NASHA Technology
- XpresHAn Technology
Products and services
- Restylane Original hyaluronic acid (HA) dermal filler designed to act like the body's own naturally produced HA, providing support and structure in the lips and smile lines (nasolabial folds). Administered by licensed healthcare professionals.
- Restylane-L HA dermal filler with lidocaine for enhanced patient comfort during injection, providing support and structure in the lips and smile lines (nasolabial folds). Administered by licensed healthcare professionals.
- Restylane Lyft with Lidocaine HA dermal filler with lidocaine for deep implantation to correct moderate-to-severe facial wrinkles and folds, augment cheeks and chin, correct age-related midface contour deficiencies, and correct volume loss in the dorsal hand. Administered by licensed healthcare professionals.
- Restylane Silk HA dermal filler specifically designed for lip augmentation and correction of perioral wrinkles, using NASHA Technology for precision and structure. Administered by licensed healthcare professionals.
- Restylane Kysse HA dermal filler designed specifically for lip augmentation and correction of upper perioral wrinkles, using XpresHAn Technology to provide flexible support that follows natural lip expressions while maintaining natural-looking results. Administered by licensed healthcare professionals.
- Restylane Refyne HA dermal filler for mid-to-deep injection to correct moderate-to-severe facial wrinkles and folds such as nasolabial folds, formulated with XpresHAn Technology for flexible refinement of dynamic facial areas. Administered by licensed healthcare professionals.
- Restylane Defyne HA dermal filler for mid-to-deep injection to correct moderate-to-severe deep facial wrinkles and folds such as nasolabial folds, and for chin augmentation to improve chin profile in patients with mild-to-moderate chin retrusion. Uses XpresHAn Technology for dynamic support. Administered by licensed healthcare professionals.
- Restylane Contour Cheek-specific HA dermal filler using XpresHAn Technology to restore natural-looking definition and shape to the cheeks while maintaining flexible movement with facial expressions; also approved for correction of temple hollowing. Administered by licensed healthcare professionals.
- Restylane Eyelight FDA-approved HA dermal filler specifically formulated to improve infraorbital hollowing (undereye hollows), using NASHA Technology with a firm gel texture for targeted product placement that stays in place. Administered by licensed healthcare professionals.
Quantifiable outcome
- 95% of people treated with Restylane still saw improvement after 18 months
- +5 more outcomes
Companies that use Restylane
Customer profileSegments2 records
Ideal customer profiles2 records
Restylane technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Restylane partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- ALASTIN SkincareminorALASTIN Skincare is listed as an ASPIRE partner brand where members can earn points for purchasing qualifying products. Points can be redeemed toward Galderma aesthetic treatments including Restylane fillers.
- SculptraUSAminorSculptra (collagen stimulator) is part of the Galderma aesthetics portfolio alongside Restylane. Cross-promoted on the Restylane website under 'Explore other Galderma Aesthetics treatments' for collagen stimulation needs.
- DysportUSAminorDysport (botulinum toxin for frown lines) is part of the Galderma aesthetics portfolio. Cross-promoted on the Restylane website under 'Explore other Galderma Aesthetics treatments' for lines between the brows.
- GAIN (Galderma Aesthetic Injector Network)coreGAIN is Galderma's professional network for aesthetic injectors providing community, education, and business development support. Healthcare professionals register at GAINconnect.com and access training resources, AARTTM of injection methodology, and practice support tools.
- ASPIRE Galderma Practice RewardscorePractice rewards program designed to strengthen relationships between aesthetic practices and patients. Benefits include: patient insights data, strategic branded communications, preferred pricing on Galderma products, and exclusive offers to extend to patients.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Restylane competitors and assessment
Company assessmentEmerging players
- Revance Therapeutics: Aesthetics-focused biotech commercializing the RHA Collection of HA fillers and DaxibotulinumtoxinA (Daxxify), increasingly competing with Restylane in both HA and longer-duration injectable categories.
- Suneva Medical: Privately held aesthetics company marketing Bellafill (a long-lasting filler) and other regenerative aesthetics products, competing for the same HCP channel with a differentiated longevity story.
- Prollenium Medical Technologies: Developer of the Revanesse line of HA dermal fillers, competing head-to-head with Restylane and Juvéderm in the same facial aesthetic treatment areas through the same HCP distribution model.
- Evolus: Disrupts the aesthetics injectable market with Jeuveau (prabotulinumtoxinA); while focused on neurotoxin today, Evolus operates in the same med-spa/aesthetic injector ecosystem and competes for provider share-of-wallet.
- Teoxane: Swiss-based aesthetics company known for the Teosyal RHA range of HA fillers; competes with Restylane in dynamic facial areas using a similar rheology-focused technology narrative.
Regional players
- Hugel (Charm Medical): South Korean aesthetics manufacturer with HA fillers and botulinum toxin products expanding globally; directly comparable product mechanism and category, currently with stronger ex-US positioning.
- Sinclair Pharma: Aesthetics-focused company with HA fillers (MaiLi) and biostimulator/EBD portfolio, comparable in product mix and channel strategy though with primary European commercial footprint.
Direct peers
- Merz Aesthetics: Markets competing HA and biostimulator fillers (Belotero, Radiesse) and the Xeomin neurotoxin via the same licensed professional channel; directly comparable product portfolio and physician-targeted GTM motion.
- Allergan Aesthetics (Juvéderm): AbbVie-owned aesthetics division whose Juvéderm franchise is the largest direct HA dermal filler competitor to Restylane, targeting the same facial areas (lips, cheeks, folds) and same licensed injector channel.
Broad incumbents
- Galderma SA: The parent company of Restylane; the broader Galderma portfolio (Sculptra, Dysport, Cetaphil) overlaps significantly in the aesthetic injectable and dermatology spaces where Restylane competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Restylane social profiles
Digital presenceRestylane financial estimates
Financial estimateRevenue estimate
Valuation estimate
Restylane leadership team
Management profileNumber of profiles
Restylane funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Restylane M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Restylane
What does Restylane do?
Restylane is a portfolio of nine FDA-approved hyaluronic acid (HA) dermal fillers sold by Galderma Laboratories, L.P. exclusively to licensed healthcare professionals for non-surgical aesthetic treatments including lip augmentation, cheek and chin enhancement, undereye hollow correction, nasolabial fold and marionette line softening, and hand rejuvenation. Products are administered by certified aesthetic injectors and built on two proprietary gel technologies — NASHA® (precision/structure) and XpresHAn™ (flexibility/movement) — to address distinct facial areas and dynamic expressions. Supporting infrastructure includes the ASPIRE Galderma Rewards loyalty program, the GAIN injector network, and the Find a Specialist locator.
Is Restylane a public or private company?
Restylane is a private company. It is classified as corporate owned and is currently operating.
When was Restylane founded?
Restylane was founded in 1996. It employs 501 to 1,000 people.
Where is Restylane based?
Restylane is headquartered in Dallas, United States, in the North America region.
How does Restylane make money?
One revenue line is on record: dermal Filler Product Sales.
Who are Restylane's main competitors?
Emerging players on record are Revance Therapeutics, Suneva Medical, Prollenium Medical Technologies, Evolus and Teoxane. Regional players are Hugel (Charm Medical) and Sinclair Pharma. Direct peers are Merz Aesthetics and Allergan Aesthetics (Juvéderm). Galderma SA is listed as a broad incumbent.
Does Restylane have an API?
No public API is recorded for Restylane.
What industry is Restylane in?
Restylane's product category is Aesthetic Dermal Fillers. Its primary akta.pro industry code is CRABALAF, Professional Skincare & Facial Treatments, with a secondary code of CRABAAAK, Professional/Backbar Skincare (Esthetician & Spa Use). Its SIC code is 2844.